| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 413.77B | 412.94B | 402.77B | 389.87B | 366.23B | 355.35B |
| Gross Profit | 188.99B | 188.78B | 180.60B | 174.61B | 179.10B | 179.87B |
| EBITDA | 49.88B | 49.55B | 43.42B | 47.31B | 46.06B | 56.37B |
| Net Income | 20.88B | 21.20B | 14.62B | 21.94B | 23.76B | 29.87B |
Balance Sheet | ||||||
| Total Assets | 468.81B | 497.17B | 486.36B | 469.28B | 428.02B | 435.50B |
| Cash, Cash Equivalents and Short-Term Investments | 80.78B | 102.24B | 85.53B | 101.08B | 97.25B | 121.53B |
| Total Debt | 29.31B | 29.74B | 30.34B | 32.17B | 8.37B | 8.12B |
| Total Liabilities | 151.52B | 181.47B | 188.23B | 190.11B | 163.01B | 190.65B |
| Stockholders Equity | 295.97B | 293.72B | 280.32B | 264.25B | 251.57B | 231.72B |
Cash Flow | ||||||
| Free Cash Flow | 13.90B | 25.60B | 5.08B | 18.82B | -23.63B | 13.80B |
| Operating Cash Flow | 36.51B | 43.66B | 30.07B | 41.96B | 19.30B | 40.73B |
| Investing Cash Flow | -17.23B | -7.66B | -34.79B | -19.54B | -34.18B | -19.87B |
| Financing Cash Flow | -11.70B | -21.20B | -11.76B | -19.82B | -10.22B | -9.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥75.69B | 24.02 | 6.66% | 3.74% | 4.06% | -22.80% | |
71 Outperform | $563.45B | 16.07 | 13.33% | 1.72% | 15.90% | 13.60% | |
71 Outperform | ¥151.48B | 19.92 | ― | 5.10% | -1.63% | 1.81% | |
68 Neutral | $297.77B | 46.33 | 3.99% | 3.92% | -0.89% | -34.14% | |
66 Neutral | $419.99B | 20.49 | 7.29% | 1.89% | 1.29% | 4.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | $387.13B | 32.89 | 5.72% | 1.98% | -6.64% | -13.78% |
Lion Corporation has announced the establishment of a wholly owned subsidiary in India, named Lion India Private Limited, as part of its Vision2030 2nd STAGE medium-term management plan. This strategic move aims to capitalize on India’s growing middle-income population and increasing health awareness, with plans to start operations in October 2026. The new subsidiary will initially focus on online marketing of the KODOMO brand for oral healthcare and skincare for babies and children, leveraging Lion’s strengths in product development and marketing. While this expansion is expected to have a minor impact on the company’s consolidated results for 2025, it positions Lion to tap into India’s burgeoning market.
The most recent analyst rating on (JP:4912) stock is a Buy with a Yen1737.00 price target. To see the full list of analyst forecasts on Lion stock, see the JP:4912 Stock Forecast page.
Lion Corporation’s financial results for the first half of 2025 show a slight increase in net sales and operating profit, despite a decrease in profit before tax and profit attributable to owners. The company’s core operating income improved significantly, indicating strong regular business performance. The financial position remains stable with a slight increase in total equity, and the company has announced an increase in cash dividends per share, reflecting confidence in future earnings.
The most recent analyst rating on (JP:4912) stock is a Buy with a Yen1750.00 price target. To see the full list of analyst forecasts on Lion stock, see the JP:4912 Stock Forecast page.